Effects of exenatide on postprandial vascular endothelial function in type 2 diabetes mellitus
Not Applicable
- Conditions
- type 2 diabetes mellitus
- Registration Number
- JPRN-UMIN000015699
- Lead Sponsor
- First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
Not provided
Exclusion Criteria
1) receiving insulin therapy; 2) having diabetic ketoacidosis, nonketotic hyperosmolar coma, infection, or acute coronary syndrome; 3) being pregnant or possibly pregnant; 4) having a history of stroke or ischemic heart disease occurring within the preceding 6 months; 5) having a history of pancreatitis; and 6) having arrhythmia.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary endpoint is the difference between changes in postprandial vascular endothelial function without eventide administration compared with single-dose exenatide administration.
- Secondary Outcome Measures
Name Time Method